With advancements in high resolution scanner technologies (HRCT), artificial intelligence (AI), and data collection, precision lung imaging (or “Quantitative CT” -- QCT) offers great value to clinical trial sponsors. 

Download this white paper to learn about the impact of imaging biomarkers on COPD drug trials.